[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100625518":3},{"organization":4,"armGroups":7,"interventions":10,"overallOfficials":11,"centralContacts":23,"locations":10,"responsibleParty":29,"collaborators":10,"id":31,"slug":32,"hasResults":33,"nctId":34,"briefTitle":35,"officialTitle":36,"acronym":10,"eligibilityCriteria":37,"healthyVolunteers":33,"sex":38,"minAge":39,"maxAge":40,"enrollmentInfo":41,"targetDuration":10,"studyType":44,"phases":10,"briefSummary":45,"conditions":46,"keywords":48,"overallStatus":50,"whyStopped":10,"lastUpdateSubmitDate":51,"lastUpdatePostDateStruct":52,"startDateStruct":55,"completionDateStruct":57,"leadSponsor":59,"locationsCount":10},{"fullName":5,"class":6},"Zagazig University","OTHER_GOV",[8],{"label":9,"type":10,"description":10,"interventionNames":10},"Ketamine dexmetamodine and propofol midazolam",null,[12,16,20],{"name":13,"affiliation":14,"role":15},"Doaa Mohamed Farid, MD","Doaa mohamed Farid","PRINCIPAL_INVESTIGATOR",{"name":17,"affiliation":18,"role":19},"Rehab Abdalla Wahdan, MD","Rehab Abdalla Wahdan","STUDY_DIRECTOR",{"name":21,"affiliation":22,"role":15},"Olfat Monium Abraham, MD","Olfat abdelmonium Ebrahim",[24],{"name":25,"role":26,"phone":27,"phoneExt":10,"email":28},"Ahmed Esam Hamad, Register","CONTACT","+201095529439","tahawy188@gmail.com",{"type":30,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100625518","comparison-between-two-drugs-in-sedation-of-upper-gi-endoscopy-100625518",false,"NCT07423676","Comparison Between Two Drugs in Sedation of Upper GI Endoscopy","Ketamine - Dexmedetomidine(Ketodex) Versus Propofol -Midazolam for Sedation in Patients Undergoing Upper Gastrointestinal Endoscopy","Inclusion Criteria\n\n* Patient acceptance\n* Adults aged 21-60 years.\n* Both sexes\n* BMI\\\u003C35 kg\u002Fm2\n* ASA physical status :I\\& II\n* Patients Undergoing Gastrointestinal endoscopy\n* Duration \\\u003C30mintues\n\nExclusion Criteria:\n\n* • Known allergy to any of the study drugs\n\n  * Unstable Cardiovascular disease\n  * Moderate to severe respiratory diseases","ALL","21 Years","60 Years",{"count":42,"type":43},52,"ESTIMATED","OBSERVATIONAL","The goal of this clinical trial is to compare time of sedation between two drugs administered to patients undergoing upper gastrointestinal endoscopy Primary outcome : Time of sedation : is the time to reach sedation score of 5 according to modified Ramsay sedation score starting from the time of injecting bolts dose of study drugs\n\nSecondary outcome :\n\n* Recovery time :is the time to reach score 2 of modified Ramsay sedation score starting from injecting bolus dose of study drugs .\n* Hemodynamics (MAP,HR) \\& oxygen saturation\n* Drug side effects (nausea,vomitting,agitation)\n* Endoscopist satisfaction",[47],"Sedation During GI Endoscopy",[49],"Sedation","NOT_YET_RECRUITING","2026-02-14",{"date":53,"type":54},"2026-02-20","ACTUAL",{"date":56,"type":43},"2026-03-01",{"date":58,"type":43},"2026-05-02",{"name":5,"class":6}]